MMSI - Merit Medical Systems, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD

Merit Medical Systems, Inc.

1600 West Merit Parkway
South Jordan, UT 84095
United States

IndustryMedical Instruments & Supplies
Full Time Employees4,150

Key Executives

Mr. Fred P. Lampropoulos1.51M267k67
Mr. Bernard J. Birkett909.14kN/A48
Mr. Ronald A. Frost405.96k187.5k55
Mr. Justin J. Lampropoulos519.18kN/A34
Mr. Joseph C. Wright655.96kN/A47
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Merit Medical Systems, Inc. designs, develops, manufactures, and markets medical products for interventional and diagnostic procedures worldwide. The company’s Cardiovascular segment offers cardiology and radiology devices for diagnosing and treating coronary arterial, peripheral vascular, and other non-vascular diseases; and embolotherapeutic products. It also provides vascular access products; guide wires, inflation devices, and diagnostic catheters for use in angiography procedures; therapeutic infusion systems and safety products; drainage catheters and drainage access products, support catheters, vascular retrieval devices, and dialysis access products; and embosphere microspheres and delivery systems, and microcatheters. In addition, this segment offers needles, scalpels, hemostasis devices, arm boards, and sheath introducers for cardiology procedures; fluid management and tubing, manifolds, syringes, transducers, and diagnostic catheters; hemostasis valves, MAP Merit Angioplasty Packs, and angioplasty accessories; cardiac rhythm management and electrophysiology devices; and various devices, accessories, kits, and procedure trays. The company’s Endoscopy segment provides gastroenterology and pulmonology devices for expanding esophageal, tracheobronchial, and biliary strictures caused by malignant tumors. It also offers non-vascular, esophageal, and biliary stents; esophageal balloon dilators; kits and accessories for the endoscopy and bronchoscopy markets; coating services for medical tubes and wires under OEM brands; and microelectromechanical systems sensor components. The company serves hospitals and clinic-based cardiologists, radiologists, neurologists, nephrologists, vascular and orthopaedic surgeons, interventional gastroenterologists and pulmonologists, physiatrists, general surgeons, thoracic surgeons, oncologists, electrophysiologists, technicians, and nurses. The company was founded in 1987 and is headquartered in South Jordan, Utah.

Corporate Governance

Merit Medical Systems, Inc.’s ISS Governance QualityScore as of October 15, 2017 is 8. The pillar scores are Audit: 2; Board: 7; Shareholder Rights: 6; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.